Top Ten Videos to watch

crime scene
Vote
Studio Portrait of Two Young Women Back to Back, One With a Tattoo
Mamie Till and Emmett Till
GOP Redistricting Plot To Unseat Rep. Corrine Brown Exposed
Protests Break Out In Charlotte After Police Shooting
'Keep the Vote Alive!' March Commemorates Civil Rights Act
White man shooting
Gun Violence Continues To Plague Chicago, Over 1,000 Shootings For Year To Date
HS Football
Gun Violence Continues To Plague Chicago, Over 1,000 Shootings For Year To Date
Police Line
US-POLITICS-OBAMA
2016 Republican National Convention
44th NAACP Image Awards - Show
MD Primary
Premiere Of OWN's 'Queen Sugar' - Arrivals
Democratic National Convention
US-VOTE-REPUBLICANS-TRUMP
Los Angeles Rams v San Francisco 49ers
US-POLICE-RACISM-UNREST
Protesters Demonstrate Against Donald Trump's Visit To Flint Michigan
President Obama Speaks On The Economy In Brady Press Briefing Room
Lil Wayne
Construction Continues On The National Museum of African American History To Open In 2016
Preacher Preaching the Gospel
Hillary Clinton Campaigns In Louisville, Kentucky
Miami Dolphins v Seattle Seahawks
US-VOTE-DEMOCRATS-CONVENTION
US-ATTACKS-9/11-ANNIVERSARY
Leave a comment

Woman holding pills close-up of hands

World — A revolution in the fight against HIV/AIDS might be around the corner, according to a new study, which found a daily pill, made of two commonly used HIV medications, lowered the risk of infection by 73 percent.

That’s for participants who took the drug almost every day. The study found a 44 percent reduction in HIV infection across all 2,499 members of the study, many of whom were taking the drug, a combination of emtricitabine and tenofovir, inconsistently.

The study, published in the New England Journal of Medicine and funded by the NIH and the Bill and Melinda Gates Foundation, is the first of its kind to show that giving people these drugs prophylactically can reduce infection risk.

This “is a significant advance in HIV prevention,” said Dr. Javier R. Lama, in a written statement. Lama is co-chair of the study protocol and based in Lima, Peru.

The study, three years in the making, looked at thousands of men and transgendered women who have sex with men across six countries. In addition to the medication, they were given safe sex counseling, condoms and care for other sexually transmitted diseases.

Similar studies are now under way for heterosexual men and women and users of injectible drugs.

Read entire article at CBSnews.com

Share this post on Facebook! CLICK HERE:

Also On News One:
comments – Add Yours